New Zealand's Ministry of Health has announced it is prosecuting Promisia, the manufacturer of arthritis supplement Arthrem, in a move the firm's CEO claims is littered with "significant factual errors".
Separate research from China and Thailand have both found that diets high in soy products could be the answer to lower hypertension risk in Asians, in contrast to traditional fruit- or vegetable-rich diets.
A trade association director is calling for better multi-sectoral cooperation in India, to minimise the need for authorities to clamp down on nutraceutical and supplement companies in India for labelling violations.
Here's a recap of our 10 most read nutrition stories in January, featuring regulatory updates from China and Australia, Nestlé's moves in the A2 milk market, the top APAC supplement trends to watch this year, and more.
China’s State Administration for Market Regulation (SAMR) and the Ministry of Commerce summoned all 91 direct-selling firms operating in China to a meeting as part of the “100-day operation” to clean up the health food market.
New Zealand’s natural products sector is facing yet another lengthy process of workshops, surveys and consultations to secure regulations that are fit-for-purpose, after the government signalled its intention to go back to the drawing board.
At least 300 cases worth roughly US$6.7m (RMB45m) have been identified since China launched a '100-day operation' to stem illegal and unethical practices across the nation's health food and supplement industry.
Marinova has commenced a clinical trial to investigate the gut health benefits of its bioactive seaweed extract, Maritech fucoidan, on elite athletes, with the broader goal of entering the sports nutrition market.
In our latest China round-up, authorities continue to crack down on Chinese supplement and health food firms, probiotics and e-commerce rule the country's supplement scene, and Nestlé pushes forth into China's A2 milk market.